3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Clinical Stage I Gastric Cancer AJCC v8
1
Breast Cancer Lymphedema
1
BTC
1
Interventions
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Cisplatin
5
pembrolizumab
4
durvalumab
4
Carboplatin
4
cemiplimab
3
Radiation
3
Platinum
3
Paclitaxel
3
Cetuximab
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
(225)Ac-DOTA-c(RGDyK)
3
cabozantinib
2
atezolizumab
2
Radiotherapy
2
Pemetrexed
2
Nivolumab
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
ALT-803
2
130-nm albumin-bound paclitaxel
2
zipalertinib
1
repotrectinib
1
poly ICLC
1
ipatasertib
1
fludarabine phosphate
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma
×
Surgical Procedures, Operative
×
30 days
×
Clear all
No trials found.